Emerging research suggests that retatrutide, a novel medication, promises to significantly impact the treatment of obesity . Unlike many current weight management drugs , retatrutide functions as both a GLP-1 receiver and a GIP receiver , targeting multiple factors involved in appetite control and glucose stability . Early medical research reve… Read More